Search results for "Anticoagulation"


 
Results 31 - 40 of about 231 for "Anticoagulation".
Sort by: Relevance | Newest | Oldest

Score may help determine safe anticoagulation with warfarin in patients with liver disease

A 4-point score may help clinicians determine which patients with chronic liver disease can safely receive warfarin, a new study reports.
https://immattersacp.org/weekly/archives/2014/05/20/6.htm
20 May 2014

COVID-19 research focused on anticoagulation, vaccine-induced thrombocytopenia

Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
https://immattersacp.org/weekly/archives/2021/06/15/1.htm
15 Jun 2021

DOACs more effective, cost-effective than LMWH for cancer-associated thrombosis

A meta-analysis compared three direct oral anticoagulants (DOACs) (apixaban, edoxaban, and rivaroxaban) to low-molecular-weight heparin (LMWH) and found that apixaban was usually the most cost-effective option, but that finding hinged on the specific drug price.
https://immattersacp.org/weekly/archives/2023/01/03/5.htm
3 Jan 2023

AHA scientific statement offers guidance on LV thrombus

Among other recommendations, clinicians should treat patients with left ventricular (LV) thrombus after myocardial infarction using oral anticoagulants for three months, the American Heart Association (AHA) said.
https://immattersacp.org/weekly/archives/2022/09/20/4.htm
20 Sep 2022

Pros, cons of prolonged anticoagulation after a clot

Experts debate about provoked vs. unprovoked venous thromboembolism, and whether a once-high-risk patient can have that status removed later.
https://immattersacp.org/archives/2020/02/pros-cons-of-prolonged-anticoagulation-after-a-clot.htm
1 Feb 2020

Diltiazem may increase bleeding risk when coadministered with DOACs in afib

A study of patients with atrial fibrillation in one U.S. health system found a 56% higher risk for bleeding-related hospitalization associated with concomitant use of diltiazem and a direct-acting oral anticoagulant (DOAC) versus a DOAC alone.
https://immattersacp.org/weekly/archives/2022/07/12/5.htm
12 Jul 2022

Self-testing, self-dosage for anticoagulation safe, suitable option for some patients, study indicates

Self-testing and self-dosage of oral anticoagulation may be safe and suitable for patients of all ages with suitable health care support as backup, according to a meta-analysis.
https://immattersacp.org/weekly/archives/2011/12/06/1.htm
6 Dec 2011

Aspirin appears to reduce recurrence of VTE after stopping anticoagulants

Aspirin reduced the risk of venous thromboembolism (VTE) recurrence with no apparent increase in major bleeding in patients who had an initial unprovoked VTE and had discontinued anticoagulant treatment, a study found.
https://immattersacp.org/weekly/archives/2012/06/05/6.htm
5 Jun 2012

Updated Beers criteria highlight medications that are risky in older patients

The American Geriatrics Society has added warfarin as a medication to avoid and urged caution with sodium-glucose cotransporter-2 inhibitors in the latest update of its guidance on prescribing for U.S. adults ages 65 years and older.
https://immattersacp.org/weekly/archives/2023/05/16/1.htm
16 May 2023

MKSAP Quiz: Evaluation for easy bruising

A 48-year-old woman is evaluated for easy bruising. She has no history of gingival bleeding, menorrhagia, or bleeding following procedures. Following a physical exam and lab studies, what is the most appropriate diagnostic test?
https://immattersacp.org/weekly/archives/2023/03/28/3.htm
28 Mar 2023

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next